Latest Insider Transactions at Unitedhealth Group Inc (UNH)
This section provides a real-time view of insider transactions for Unitedhealth Group Inc (UNH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of UNITEDHEALTH GROUP INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of UNITEDHEALTH GROUP INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 18
2022
|
Andrew Witty CEO, UHG |
SELL
Open market or private sale
|
Direct |
11,376
-12.94%
|
$5,995,152
$527.9 P/Share
|
|
Jul 01
2022
|
Timothy Patrick Flynn Director |
BUY
Grant, award, or other acquisition
|
Direct |
170
+2.01%
|
-
|
|
Jul 01
2022
|
Paul R Garcia Director |
BUY
Grant, award, or other acquisition
|
Direct |
161
+2.93%
|
-
|
|
Jul 01
2022
|
Stephen J Hemsley Director |
BUY
Grant, award, or other acquisition
|
Direct |
266
+0.04%
|
-
|
|
Jul 01
2022
|
Michele J Hooper Director |
BUY
Grant, award, or other acquisition
|
Direct |
100
+0.27%
|
-
|
|
Jul 01
2022
|
Frederick William Mcnabb Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
172
+1.49%
|
-
|
|
Jul 01
2022
|
Rice Valerie Md Montgomery Director |
BUY
Grant, award, or other acquisition
|
Direct |
171
+2.09%
|
-
|
|
Jul 01
2022
|
John H Noseworthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
170
+4.56%
|
-
|
|
Jun 28
2022
|
Rupert M Bondy EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7
+0.3%
|
-
|
|
Jun 28
2022
|
Dirk C Mc Mahon President & COO, UHG |
BUY
Grant, award, or other acquisition
|
Direct |
59
+0.09%
|
-
|
|
Jun 28
2022
|
Erin Mc Sweeney EVP & Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26
+0.32%
|
-
|
|
Jun 28
2022
|
John F Rex President & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
60
+0.04%
|
-
|
|
Jun 28
2022
|
Thomas E Roos Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22
+0.06%
|
-
|
|
Jun 28
2022
|
Brian R Thompson CEO, UnitedHealthcare |
BUY
Grant, award, or other acquisition
|
Direct |
40
+0.16%
|
-
|
|
Jun 28
2022
|
Andrew Witty CEO, UHG |
BUY
Grant, award, or other acquisition
|
Direct |
111
+0.13%
|
-
|
|
Jun 28
2022
|
Timothy Patrick Flynn Director |
BUY
Grant, award, or other acquisition
|
Direct |
22
+0.27%
|
-
|
|
Jun 28
2022
|
Paul R Garcia Director |
BUY
Grant, award, or other acquisition
|
Direct |
1
+0.04%
|
-
|
|
Jun 28
2022
|
Michele J Hooper Director |
BUY
Grant, award, or other acquisition
|
Direct |
110
+0.29%
|
-
|
|
Jun 28
2022
|
Frederick William Mcnabb Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.14%
|
-
|
|
Jun 28
2022
|
Rice Valerie Md Montgomery Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.33%
|
-
|
|
Jun 28
2022
|
John H Noseworthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.32%
|
-
|
|
Jun 28
2022
|
Stephen J Hemsley Director |
BUY
Grant, award, or other acquisition
|
Direct |
22
+0.0%
|
-
|
|
Jun 24
2022
|
Erin Mc Sweeney EVP & Chief People Officer |
SELL
Open market or private sale
|
Direct |
0
|
$0
$492.75 P/Share
|
|
Jun 23
2022
|
Erin Mc Sweeney EVP & Chief People Officer |
SELL
Open market or private sale
|
Direct |
1,273
-13.58%
|
$635,227
$499.0 P/Share
|
|
Jun 07
2022
|
Erin Mc Sweeney EVP & Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
125
-1.32%
|
$62,125
$497.1 P/Share
|
|
Jun 07
2022
|
Brian R Thompson CEO, UnitedHealthcare |
SELL
Payment of exercise price or tax liability
|
Direct |
253
-1.0%
|
$125,741
$497.1 P/Share
|
|
Jun 06
2022
|
Rupert M Bondy EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,296
+50.0%
|
-
|
|
Jun 03
2022
|
Andrew Witty CEO, UHG |
SELL
Payment of exercise price or tax liability
|
Direct |
5,294
-2.87%
|
$2,567,590
$485.61 P/Share
|
|
May 26
2022
|
Frederick William Mcnabb Iii Director |
BUY
Open market or private purchase
|
Direct |
89
+0.78%
|
$44,856
$504.32 P/Share
|
|
May 19
2022
|
Richard T Burke Director |
SELL
Open market or private sale
|
Indirect |
2,500
-0.21%
|
$1,195,000
$478.96 P/Share
|
|
May 17
2022
|
Richard T Burke Director |
SELL
Open market or private sale
|
Indirect |
2,500
-0.2%
|
$1,232,500
$493.5 P/Share
|
|
May 16
2022
|
Richard T Burke Director |
SELL
Open market or private sale
|
Indirect |
2,500
-0.2%
|
$1,232,500
$493.25 P/Share
|
|
Apr 04
2022
|
Stephen J Hemsley Director |
SELL
Bona fide gift
|
Indirect |
131,684
-100.0%
|
-
|
|
Apr 01
2022
|
Richard T Burke Director |
BUY
Grant, award, or other acquisition
|
Direct |
100
+0.07%
|
-
|
|
Apr 01
2022
|
Timothy Patrick Flynn Director |
BUY
Grant, award, or other acquisition
|
Direct |
171
+2.07%
|
-
|
|
Apr 01
2022
|
Paul R Garcia Director |
BUY
Grant, award, or other acquisition
|
Direct |
161
+3.12%
|
-
|
|
Apr 01
2022
|
Stephen J Hemsley Director |
BUY
Grant, award, or other acquisition
|
Direct |
269
+0.04%
|
-
|
|
Apr 01
2022
|
Michele J Hooper Director |
BUY
Grant, award, or other acquisition
|
Direct |
100
+0.27%
|
-
|
|
Apr 01
2022
|
John H Noseworthy Director |
BUY
Grant, award, or other acquisition
|
Direct |
171
+4.81%
|
-
|
|
Apr 01
2022
|
Gail R Wilensky |
BUY
Grant, award, or other acquisition
|
Direct |
100
+0.4%
|
-
|
|
Apr 01
2022
|
Frederick William Mcnabb Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
174
+1.53%
|
-
|
|
Apr 01
2022
|
Rice Valerie Md Montgomery Director |
BUY
Grant, award, or other acquisition
|
Direct |
166
+2.12%
|
-
|
|
Mar 24
2022
|
Richard T Burke Director |
SELL
Open market or private sale
|
Indirect |
3,000
-0.24%
|
$1,524,000
$508.8 P/Share
|
|
Mar 23
2022
|
Richard T Burke Director |
SELL
Open market or private sale
|
Indirect |
3,000
-0.24%
|
$1,515,000
$505.67 P/Share
|
|
Mar 22
2022
|
John F Rex President & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
53
+0.04%
|
-
|
|
Mar 22
2022
|
Stephen J Hemsley Director |
BUY
Grant, award, or other acquisition
|
Direct |
19
+0.0%
|
-
|
|
Mar 22
2022
|
Gail R Wilensky |
BUY
Grant, award, or other acquisition
|
Direct |
68
+0.28%
|
-
|
|
Mar 22
2022
|
Richard T Burke Director |
SELL
Open market or private sale
|
Indirect |
4,000
-0.32%
|
$2,044,000
$511.14 P/Share
|
|
Mar 22
2022
|
Richard T Burke Director |
BUY
Grant, award, or other acquisition
|
Direct |
77
+0.05%
|
-
|
|
Mar 22
2022
|
Timothy Patrick Flynn Director |
BUY
Grant, award, or other acquisition
|
Direct |
19
+0.24%
|
-
|